Community Health Services, Guidance

Applied filters

Care Setting (20)
- Adults (8)
- Care homes (8)
- Care of the elderly (1)
- Community Health Services (20)
- Health and Justice (14)
- Occupational Health (3)
- Palliative and End of Life Care (2)
- Primary Care (17)
- Transfer of care (9)
- Trusts (17)
Guidance (20)
- Administering (8)
- Adverse effects (1)
- Implementation (1)
- Medication Safety (2)
- Patient Group Directions (11)
- Policy, Commissioning and Managerial (2)
- Preparing (1)
- Service advice and planning (2)
- Supply (9)
Medicine (2)
- Almotriptan (1)
- Amitriptyline (1)
- Bupropion (1)
- Buspirone (1)
- Carbamazepine (1)
- Chlorphenamine (1)
- Citalopram (1)
- Clomipramine (1)
- Dextromethorphan (1)
- Dosulepin (1)
- Doxepin (1)
- Duloxetine (1)
- Eletriptan (1)
- Ergotamine (1)
- Escitalopram (1)
- Fentanyl (1)
- Fluoxetine (1)
- Fluvoxamine (1)
- Frovatriptan (1)
- Granisetron (1)
- Imipramine (1)
- Influenza vaccine (1)
- Isocarboxazid (1)
- Levodopa (1)
- Linezolid (1)
- Lithium (1)
- Lofepramine (1)
- Methadone (1)
- Methylthioninium chloride (1)
- Metoclopramide (1)
- Mirtazapine (1)
- Moclobemide (1)
- Naratriptan (1)
- Nortriptyline (1)
- Ondansetron (1)
- Oxitriptan (1)
- Oxycodone (1)
- Paroxetine (1)
- Pentazocine (1)
- Pethidine (1)
- Phenelzine (1)
- Procarbazine (1)
- Rasagiline (1)
- Rizatriptan (1)
- Selegiline (1)
- Sertraline (1)
- St. John's wort (1)
- Sumatriptan (1)
- Tapentadol (1)
- Tramadol (1)
- Tranylcypromine (1)
- Trazodone (1)
- Trimipramine (1)
- Tryptophan (1)
- Venlafaxine (1)
- Zolmitriptan (1)
Medicines planning (4)
- Patient Group Direction Planning (4)
Publications (3)
- Research and audits (1)
- Summary advice (1)
- Templates (1)
Specialty (2)
- Mental health and illness (1)
- Vaccinating (1)

Patient Group Direction use in Hospital at Home, including virtual ward, services

28 March 2023Considerations required before implementing Patient Group Direction (PGDs) in Hospital at Home, including virtual ward, services

When Patient Group Directions are not required

29 June 2022Guidance on when PGDs should not be used and advice on alternative mechanisms for supply and administration of medicines

Worked example of assessing the risk of transcribing

22 February 2022Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.

Transcribing in the patient's home with healthcare input

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input

Non-acute settings with healthcare input and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input

Semi-acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.

Alternatives to transcribing for medicines administration

22 February 2022Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.

Understanding transcribing for medicines administration

22 February 2022Transcribing for medicines administration in healthcare requires assessment and mitigation against identified risks. These risks vary according to setting.

Nursing Associates, Physician Associates and the use of PGDs

16 November 2021A summary is provided on the legal position on the use of Patient Group Directions by Nursing Associates and Physician Associates

SPS - Specialist Pharmacy Service

NHS